Felix Orben

ORCID

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 3

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

EMBO molecular medicine

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Katja Peschke, Hannah Jakubowsky, Arlett Schäfer, Hans Carlo Maurer, Sebastian Lange, Felix Orben, Raquel Bernad, Felix N Harder, Matthias Eiber, Rupert Öllinger, Katja Steiger, Melissa Schlitter, Wilko Weichert, Ulrich Mayr, Veit Phillip, Christoph Schlag, Roland M Schmid, Rickmer F Braren, Bo Kong, Ihsan Ekin Demir, Helmut Friess, Roland Rad, Dieter Saur, Günter Schneider, Maximilian Reichert
Identification of treatment-induced vulnerabilities in pancreatic cancer patients using functional model systems. EMBO molecular medicine 14 (4) (2022)
Josefina Doffo, Stefanos A Bamopoulos, Hazal Köse, Felix Orben, Chuanbing Zang, Miriam Pons, Alexander T den Dekker, Rutger W W Brouwer, Apoorva Baluapuri, Stefan Habringer, Maximillian Reichert, Anuradha Illendula, Oliver H Krämer, Markus Schick, Elmar Wolf, Wilfred F J Van IJcken, Irene Esposito, Ulrich Bernd Keller, Günter Schneider, Matthias Wirth
NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 119 (9) (2022)
Christian Schneeweis, Zonera Hassan, Katja Ascherl, Matthias Wirth, Stella Koutsouli, Felix Orben, Lukas Krauß, Carolin Schneider, Rupert Öllinger, Oliver H Krämer, Roland Rad, Maximilian Reichert, Maria S Robles, Dieter Saur, Günter Schneider
Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition. Cancer communications (London, England) 42 (4) (2022)

Felix Orben.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Felix Orben